Our invention concerns a mixture of CLA glycerides, and/or CLA-fatty acids and
or CLA-alkyl esters and another component, wherein the other component (=component
A) is selected for its capacity to alleviate problems related to insulin resistance
in mammals, using CLA rich diets and/or foods and/or food supplements using an
appropriate in vitro test so that in at least one step of the in vitro test, as
described in the text, an improvement in test results is obtained of at least 4%
by the blend of the CLA derivative and component A when compared to the CLA derivative only.
The inventon further concerns CLA rich dietic food, food supplements and foods
containing the combination of CLA and component A as defined, while also the use
of this combination for achieving an alleviation of insulin resistance is part
of the invention.